iHateHospitals.com

DRUGS & RX: See Web site for additional information on this current drug shortage

View the source of this article…

Drug Shortages: Current Drug Shortages; Zanosar (Streptozocin) Injection was another wonderful and informative drug and pharmaceutical article from your drug and pharmacy information clearance-house iHateHospitals.com!

Hospital Tags: pharmaceutical, Medical News, us, drugs, drug, hospital, pharmacy, fda, information, Vioxx [...]

DRUGS & RX: See Web site for additional information on this current drug shortage

View the source of this article…

Drug Shortages: Current Drug Shortages; Methadone Hydrochloride Injection was another wonderful and informative drug and pharmaceutical article from your drug and pharmacy information clearance-house iHateHospitals.com!

Hospital Tags: Vioxx Lawsuit, rx, information, fda, hospitals, hospital, drugs, Medical News, pharmaceutical, [...]

DRUGS & RX: The U.S. Food and Drug Administration announced it has cleared for marketing a non-invasive test that uses molecular expression techniques to assist doctors in managing heart transplant patients post-surgery for potential organ rejection.

View the source of this article…

FDA Clears Test to Help Doctors Manage Heart Transplant Patients was another wonderful and informative [...]

DRUGS & RX: The U.S. Food and Drug Administration today approved Nplate (romiplostim), the first product that directly stimulates the bone marrow to produce needed platelets in patients with a rare blood disorder that can lead to serious bleeding.

View the source of this article…

FDA Approves First Bone Marrow Stimulator to Treat Immune-Related Low Platelet Counts [...]

DRUGS & RX: The U.S. Food and Drug Administration (FDA) is warning consumers against eating certain frozen cooked mussel products made by Bantry Bay Seafoods, imported from Ireland, because they may be contaminated with azaspiracid toxins, a group of naturally occurring marine toxins known to cause nausea, vomiting, diarrhea, and stomach cramps.

View the source of [...]

DRUGS & RX: The U.S. Food and Drug Administration has approved Xenazine (tetrabenazine) for the treatment of chorea in people with Huntington’s disease. Chorea is the jerky, involuntary movement that occurs in people with this disease.

View the source of this article…

FDA Approves First Drug for Treatment of Chorea in Huntington’s Disease was another wonderful and [...]

DRUGS & RX: ANTONY, France, August 27, 2008 /PRNewswire-FirstCall/ –
- Oralair(R) Grasses 300IR Highly Positive Clinical Results in a Pharmacodynamic Study Conducted in an Allergen Challenge Chamber
Stallergenes S.A. announces the highly positive results of a…

View the source of this article…

Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber was another [...]

DRUGS & RX: CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aug 27, 2008 - Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing next generation proprietary targeted medicines for cancer treatment, today announced the publication of preclinical data…

View the source of this article…

Curis Announces Nature Publication Elucidating a Paracrine Mechanism of Action in Hedgehog-Expressing Tumors was another wonderful [...]

DRUGS & RX: Studies demonstrate efficacy and safety of VisonacTM and the potential for a simplified Photodynamic Therapy (PDT) procedure for treatment of moderate to severe acne
Oslo, Norway, August 27, 2008 - Photocure announces positive preliminary results…

View the source of this article…

Photocure Announces Positive Phase II Results with Visonac for Acne was another wonderful and [...]

DRUGS & RX: INDIANAPOLIS, August 26, 2008 /PRNewswire/ — Semafore Pharmaceuticals Inc. presented data at the Seventh International Congress on Targeted Therapies in Cancer in Washington, D.C., announcing the discovery of novel multi-targeted kinase inhibitors…

View the source of this article…

Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors was another wonderful and informative drug and pharmaceutical article [...]

DRUGS & RX: LONDON, 27 August 2008: Ark Therapeutics Group plc (“Ark” or the “Company”) today nnounces that enrolment of patients into its Phase III pilot study for VitorTM (Study 208) has commenced. VitorTM is Ark’s product to…

View the source of this article…

Ark’s Vitor commences patient enrolment into Phase III pilot study was another wonderful [...]

DRUGS & RX: PRINCETON, N.J. & NEW YORK–(BUSINESS WIRE)–Aug 26, 2008 - Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc (NYSE: PFE) provided an update on the apixaban clinical development program today. The companies announced that new Phase II data…

View the source of this article…

Bristol-Myers Squibb and Pfizer Provide Update on Apixaban Clinical Development Program [...]